Infinity

Quantum Materials, LLC Acquires the Innegra™ Portfolio of High-Performance Fibers

Retrieved on: 
Tuesday, October 24, 2023
Quantum, CAMX, QTI, GA, Acquisition, Twitchell, Infinity, Innegra S

COLFAX, N.C., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Quantum Materials, LLC (“Quantum”), a vertically integrated manufacturer of multifilament and monofilament yarns, elastomeric woven suspension fabrics and industrial textiles, has acquired the Innegra™ portfolio of patented high-performance fibers and materials.

Key Points: 
  • COLFAX, N.C., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Quantum Materials, LLC (“Quantum”), a vertically integrated manufacturer of multifilament and monofilament yarns, elastomeric woven suspension fabrics and industrial textiles, has acquired the Innegra™ portfolio of patented high-performance fibers and materials.
  • Quantum has accelerated its capital expenditure plan over the last three years to expand the company’s manufacturing asset base to meet increased demand for domestic textile production.
  • We are excited to incorporate Innegra and its patented range of fibers and materials into our product portfolio,” said Allen Smith, CEO of QTI Fibers.
  • Quantum will be exhibiting the Innegra brand at the upcoming CamX show (Booth #G23) in Atlanta, GA from October 31 through November 2, 2023.

IGT Exhibits Next Generation of Growth-Driving Lottery Solutions at NASPL 2023

Retrieved on: 
Wednesday, October 25, 2023
IGT, Princess, Sale, Growth, International Game Technology, NYSE, Wheel of Fortune, Omnichannel, State, Artificial intelligence, Marketing, Partnership, Infinity, Member, CRM, IHeartRadio, Investment

LONDON, Oct. 25, 2023 /PRNewswire/ -- International Game Technology PLC ("IGT") (NYSE: IGT) announced today that it will demonstrate its global lottery industry leadership and present sophisticated lottery solutions at the North American Association of State and Provincial Lotteries ("NASPL") 2023 annual conference, from Oct. 31 – Nov. 2, in Milwaukee, Wisc.

Key Points: 
  • LONDON, Oct. 25, 2023 /PRNewswire/ -- International Game Technology PLC ("IGT") (NYSE: IGT) announced today that it will demonstrate its global lottery industry leadership and present sophisticated lottery solutions at the North American Association of State and Provincial Lotteries ("NASPL") 2023 annual conference, from Oct. 31 – Nov. 2, in Milwaukee, Wisc.
  • "IGT's decades of lottery industry leadership paired with our innovative, progressive mindset serve as the foundation for our latest portfolio of solutions on display at NASPL 2023," said Jay Gendron, IGT Chief Operating Officer Global Lottery.
  • "Our 'Future Forward, Growth Driven' theme demonstrates the investments we are making to introduce modern lottery solutions that enable customer growth and provide premier player experiences."
  • Next-Generation Retail Lottery Solutions: IGT will exhibit its next generation of terminals and innovative self-service and in-lane retail solutions.

Infinity Laboratories Unveils New Brand at AAPS 2023 PharmaSci 360 in Orlando, FL

Retrieved on: 
Monday, October 23, 2023
Laboratory, Partnership, Collection, Patient, Commercial Operating System, CASTLE, Infinity, Annual general meeting, SVP, AAPS, Pharmaceutical industry

CASTLE ROCK, Colo., Oct. 23, 2023 /PRNewswire/ -- Infinity Laboratories is thrilled to officially unveil its new brand identity at the AAPS 2023 PharmaSci 360 Annual Meeting from October 22nd to the 25th in Orlando, Florida.

Key Points: 
  • CASTLE ROCK, Colo., Oct. 23, 2023 /PRNewswire/ -- Infinity Laboratories is thrilled to officially unveil its new brand identity at the AAPS 2023 PharmaSci 360 Annual Meeting from October 22nd to the 25th in Orlando, Florida.
  • As the paramount gathering for pharmaceutical scientists, Infinity Laboratories eagerly anticipates discussions about its refreshed brand image and integrated service offerings with current and prospective partners.
  • The brand promise that Infinity Laboratories makes to its partners, and the attributes we consistently aspire to deliver, accurately convey our evolution as a premier laboratory services provider," said Joe Troxell, CEO of Infinity Laboratories.
  • Infinity Laboratories cordially invites participants at the AAPS 2023 PharmaSci 360 Annual Meeting to visit Booth #3346 to learn more about its new brand and capabilities that support the pharmaceutical industry.

EVENT ADVISORY - AZRIELI FOUNDATION TO RECOGNIZE CANADA'S LEADERS IN NEURODIVERSE EMPLOYMENT

Retrieved on: 
Thursday, October 19, 2023
CBC, David Azrieli, Infinity, Dragons' Den, Azrieli Center, Employment, Advisory Council

TORONTO, Oct. 19, 2023 /CNW/ - Next Wednesday, October 25, the Azrieli Foundation will present the first annual INfinity Prize to a Canadian social enterprise for outstanding leadership in employing neurodiverse talent.

Key Points: 
  • TORONTO, Oct. 19, 2023 /CNW/ - Next Wednesday, October 25, the Azrieli Foundation will present the first annual INfinity Prize to a Canadian social enterprise for outstanding leadership in employing neurodiverse talent.
  • The event will bring together experts in inclusive employment and social impact, members of the business community, leaders with experience employing neurodiverse talent, and people in the neurodivergent community.
  • Former Canadian "Dragon" Jim Treliving will be one of the panel experts at the live event.
  • Azrieli Foundation and Advisory Council Members:

Infinity Pharmaceuticals, Inc. : Please contact the Portnoy Law Firm to recover your losses; October 16, 2023, deadline.

Retrieved on: 
Monday, October 16, 2023
Infinity, Defendant, The Company, Breast cancer

LOS ANGELES, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Infinity Pharmaceuticals, Inc. ("Infinity" or the "Company") (NASDAQ: INFI) . investors that a lawsuit filed on behalf of investors that purchased Infinity securities between January 5, 2023 and July 24, 2023, both dates inclusive (the “Class Period”).

Key Points: 
  • LOS ANGELES, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Infinity Pharmaceuticals, Inc. ("Infinity" or the "Company") (NASDAQ: INFI) .
  • Investors are encouraged to contact attorney Lesley F. Portnoy , by phone 844-767-8529 or email : [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com .
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

INFI MONDAY DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action – INFI

Retrieved on: 
Friday, October 13, 2023
Titan, Partnership, Breast cancer, Infinity, Court, Advertising, I-Space (Chinese company), Class, Insurance, Tobacco

WHAT TO DO NEXT: To join the Infinity class action, go to https://rosenlegal.com/submit-form/?case_id=18465 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Infinity class action, go to https://rosenlegal.com/submit-form/?case_id=18465 or call Phillip Kim, Esq.
  • If you wish to serve as lead plaintiff, you must move the Court no later than October 16, 2023.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFI

Retrieved on: 
Wednesday, October 11, 2023
Pomerantz, LLP, Breast cancer, Infinity, Mergers and acquisitions, Head, News, Pharmaceutical industry, Cryptocurrency, Webcast

NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Infinity Pharmaceuticals, Inc. (“Infinity” or the “Company”) (NASDAQ: INFI).

Key Points: 
  • NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Infinity Pharmaceuticals, Inc. (“Infinity” or the “Company”) (NASDAQ: INFI).
  • The investigation concerns whether Infinity and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Then, on July 24, 2023, Infinity announced that it was terminating the Merger after failing to obtain stockholder approval.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Check Point Launches Game-Changing SASE Solution: Delivering 2x Faster Internet Security

Retrieved on: 
Wednesday, October 11, 2023
Internet access, Secure access service edge, Internet, Perimeter 81, Forrester, Infinity, Organization, Hybrid, Quantum, Unified managed account, Architecture, SASE, Policy, SAN, Point, Security Service, Internet of things, Privacy, Video game, Microscope, Online shopping

It enhances the company’s Infinity architecture with a unified SASE solution offering (1) 2x faster internet security, (2) full mesh Zero Trust Access, and (3) Secured SD-WAN with industry-leading threat prevention.

Key Points: 
  • It enhances the company’s Infinity architecture with a unified SASE solution offering (1) 2x faster internet security, (2) full mesh Zero Trust Access, and (3) Secured SD-WAN with industry-leading threat prevention.
  • Organizations are moving from on-premises internet security to internet security delivered in the cloud.
  • "With Quantum SASE, Check Point stands as the pioneer security partner, offering a Hybrid SASE solution comprised of three pivotal components: on-device network protection, cloud network protection, and a unified security gateway with built-in SD-WAN and IoT security.
  • Check Point is deeply committed to delivering the next generation of SASE and prevention-first security.

Anson and Cable Car Send Letter to MEI Pharma Stockholders

Retrieved on: 
Tuesday, October 10, 2023
Partnership, Acquisition, Common, Letter, DATE, CARD, Biotechnology, Failure, SIGN, Clinical trial, Hoarding, SAN, MEI, Hand, Security (finance), Research, TIME, Holding company, Pharmaceutical industry, Property management, Cryptocurrency, Tobacco, Mail, Infinity, By-law

TORONTO and SAN FRANCISCO, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Anson Funds (“Anson”) and Cable Car Capital LLC (“Cable Car” and, together with Anson, “we” or “us”), which collectively beneficially own approximately 19.9% of the outstanding common stock of MEI Pharma, Inc. (the “Company” or “MEIP”) (Nasdaq: MEIP), today announced that they have delivered a letter to MEIP stockholders and filed new definitive consent materials with the Securities and Exchange Commission in connection with their solicitation of written consents from stockholders in lieu of a stockholder meeting to remove the entire Board of Directors of MEIP for cause.  

Key Points: 
  • The full text of the letter to MEIP stockholders follows:
    IT IS TIME FOR CHANGE AT MEI PHARMA, INC.
    Anson Funds (“Anson”) and Cable Car Capital LLC (“Cable Car” and, together with Anson, “we” or “us”) collectively beneficially own approximately 19.9% of the outstanding common stock of MEI Pharma, Inc. (the “Company” or “MEIP”), making us the Company’s largest stockholders.
  • We wish we could say the same about the current Board, which has remained steadfast in refusing to return capital to stockholders.
  • Based on the stockholders’ rejection of the merger, it is clear that fellow stockholders shared our beliefs.
  • We believe MEIP stockholders deserve a Board that will truly look out for stockholders’ best interest and ensure management accountability.

DEADLINE ALERT for APLD, INFI, and GCT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, October 9, 2023
Cloud, Investment, Registration statement, Breast cancer, Infinity, Defendant, Applied Digital Data Systems, Law, Digital, Register, Suite, Security (finance)

LOS ANGELES, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • The Law Offices of Frank R. Cruz, Los Angeles